At what Glomerular Filtration Rate (GFR) is a patient considered for kidney transplant evaluation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Kidney Transplant Evaluation Based on GFR

Patients should be referred for kidney transplant evaluation when their GFR falls below 30 mL/min/1.73 m², and more specifically, living donor preemptive transplantation should be considered when GFR is below 20 mL/min/1.73 m² with evidence of progressive and irreversible chronic kidney disease over the preceding 6-12 months. 1

GFR Thresholds for Transplant Evaluation

Initial Evaluation Threshold: GFR <30 mL/min/1.73 m²

  • Patients willing to receive a kidney transplant should undergo transplant evaluation when GFR drops below 30 mL/min/1.73 m² (Grade B recommendation), unless they have unacceptable surgical risk or fail to meet United Network for Organ Sharing (UNOS) Ethics Committee criteria for transplant candidacy 1

  • This early referral threshold allows adequate time for comprehensive evaluation, donor identification, and preparation, which is particularly important given that sensitization may complicate organ matching and prolong wait times 1

Listing Threshold: GFR <20 mL/min/1.73 m²

  • Living donor preemptive kidney transplantation should be considered when GFR falls below 20 mL/min/1.73 m², provided there is documented evidence of progressive and irreversible CKD over the preceding 6-12 months 1

  • This timing allows for optimal preparation while avoiding premature listing when kidney function may still be adequate 1

Clinical Algorithm for Transplant Referral

Step 1: Monitor GFR Trajectory

  • Begin discussing renal replacement therapy modalities, including transplantation, when GFR drops below 30 mL/min/1.73 m² 1
  • Assess rate of GFR decline over 6-12 months to document progressive disease 1

Step 2: Initiate Evaluation Process

  • Refer all patients without clear contraindications for formal transplant evaluation at GFR <30 mL/min/1.73 m² 1
  • Evaluation should occur well before the GFR reaches 20 mL/min/1.73 m², as the process may take considerable time, especially in sensitized patients 1

Step 3: Prepare for Listing

  • Complete transplant evaluation and prepare for listing when GFR approaches 20 mL/min/1.73 m² 1
  • For living donor transplantation, proceed with transplant when GFR is <20 mL/min/1.73 m² with documented progression 1

Important Caveats and Considerations

Timing Considerations

  • Early referral at GFR <30 mL/min/1.73 m² does not necessarily mean immediate listing—it allows time for comprehensive evaluation, education about transplant options, identification of living donors, and completion of necessary medical optimization 1

  • The actual timing of transplantation may vary based on donor availability, with living donor transplants typically occurring earlier than deceased donor transplants 1

Risk Stratification

  • Timely referral for RRT planning is recommended when the predicted risk of kidney failure within 1 year is 10-20% or higher using validated risk prediction tools 1
  • This approach helps identify patients who will benefit most from early transplant evaluation 1

Special Populations

  • Patients with failed kidney allografts should be referred for re-transplant evaluation when their estimated GFR approaches 20 mL/min/1.73 m² 1
  • Sensitized patients may require even earlier referral due to increased complexity in finding compatible organs 1

Multidisciplinary Approach

  • Transplant evaluation should occur in coordination with a multidisciplinary team that includes access to dietary counseling, education about RRT modalities, transplant options, vascular access surgery, and psychological/social care 1

Conservative Management Option

  • For patients who choose not to pursue transplantation, conservative management with comprehensive supportive care should be discussed as an alternative when GFR falls below 30 mL/min/1.73 m² 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.